WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 35 filers reported holding WEREWOLF THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qube Research & Technologies Ltd | 2 | $4 | 0.00% |
| JPMORGAN CHASE & CO | 748 | $1,601 | 0.00% |
| Renaissance Technologies | 45,200 | $97 | 0.00% |
| Edgewood Management | 50,000 | $107,000 | 0.00% |
| ROYAL BANK OF CANADA | 335 | $1,000 | 0.00% |
| VANGUARD GROUP INC | 547,651 | $1,171,973 | 0.00% |
| UBS Group AG | 1,000 | $2,140 | 0.00% |
| PRUDENTIAL FINANCIAL INC | 15,400 | $32,956 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 58,128 | $124,394 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,531,924 | $3,278,318 | 0.00% |
| WELLS FARGO & COMPANY/MN | 146 | $312 | 0.00% |
| NORTHERN TRUST CORP | 26,067 | $55,783 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 174,250 | $373,006 | 0.00% |
| STATE STREET CORP | 50,768 | $108,644 | 0.00% |
External links
This page lists WEREWOLF THERAPEUTICS INC's shareholders in Q3 2023. To view WEREWOLF THERAPEUTICS INC's shareholder history, click here.